Norden Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $859K | Buy |
35,455
+2,828
| +9% | +$68.6K | 0.09% | 214 |
|
|
2025
Q1 | $827K | Buy |
32,627
+1,065
| +3% | +$27K | 0.1% | 204 |
|
|
2024
Q4 | $837K | Sell |
31,562
-19,373
| -38% | -$514K | 0.09% | 225 |
|
|
2024
Q3 | $1.47M | Buy |
50,935
+4,605
| +10% | +$133K | 0.17% | 126 |
|
|
2024
Q2 | $1.3M | Buy |
46,330
+15,994
| +53% | +$448K | 0.26% | 82 |
|
|
2024
Q1 | $842K | Buy |
30,336
+6,404
| +27% | +$178K | 0.17% | 141 |
|
|
2023
Q4 | $689K | Sell |
23,932
-2,535
| -10% | -$73K | 0.12% | 103 |
|
|
2023
Q3 | $878K | Buy |
+26,467
| New | +$878K | 0.29% | 81 |
|